Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$17,500.00
Investigating Ubiquitin Dynamics and its Involvement in Chromosome Instability and Colorectal Cancer
FY 2019-20
Summary
"In Canada, colorectal cancer is the second most common cancer diagnosis and one of the leading causes of cancer-related deaths. To develop new therapies to improve patient outcomes a deeper understanding of the events driving colorectal cancer development and progression is crucial. In this regard, preliminary data from the McManus laboratory have recently identified a set of cellular processes (ubiquitination and deubiquitination) that when altered, are suspected to drive cancer development and progression. Conceptually, these cellular processes serve to add and remove specific marks (ubiquitin) onto or from proteins, respectively, to impact their location and function. My project will use genetic, biochemical and microscopy-based approaches to investigate ~700 genes regulating these marks to identify those that when mutated, may drive the development and progression of colorectal cancer. Using relevant cellular models, I will turn each gene off and determine the downstream impact on chromosome numbers (structural bodies of DNA within cells), as abnormal chromosome numbers (chromosome instability) is a driver of many cancer types. These models will be used to determine whether loss of these proteins enables normal human cells to acquire key characteristics associated with cancer development. The results of this study will generate new insight into the abnormal molecular origins (i.e. mutated genes) driving colorectal cancer development and progression. In addition, these findings will reveal new therapeutic targets that can ultimately be exploited to develop the next generation of therapies aimed at improving the lives and outcomes of those living with colorectal cancer, or perhaps many additional cancer types."
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
429071
Name
Rutherford Kailee
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating Ubiquitin Dynamics and its Involvement in Chromosome Instability and Colorectal Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chromosome Instability (Cin); Colorectal Cancer; Deubiquitylation; Reverse Genetics; Ubiquitylation
Abstract
"In Canada, colorectal cancer is the second most common cancer diagnosis and one of the leading causes of cancer-related deaths. To develop new therapies to improve patient outcomes a deeper understanding of the events driving colorectal cancer development and progression is crucial. In this regard, preliminary data from the McManus laboratory have recently identified a set of cellular processes (ubiquitination and deubiquitination) that when altered, are suspected to drive cancer development and progression. Conceptually, these cellular processes serve to add and remove specific marks (ubiquitin) onto or from proteins, respectively, to impact their location and function. My project will use genetic, biochemical and microscopy-based approaches to investigate ~700 genes regulating these marks to identify those that when mutated, may drive the development and progression of colorectal cancer. Using relevant cellular models, I will turn each gene off and determine the downstream impact on chromosome numbers (structural bodies of DNA within cells), as abnormal chromosome numbers (chromosome instability) is a driver of many cancer types. These models will be used to determine whether loss of these proteins enables normal human cells to acquire key characteristics associated with cancer development. The results of this study will generate new insight into the abnormal molecular origins (i.e. mutated genes) driving colorectal cancer development and progression. In addition, these findings will reveal new therapeutic targets that can ultimately be exploited to develop the next generation of therapies aimed at improving the lives and outcomes of those living with colorectal cancer, or perhaps many additional cancer types."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rutherford, Kailee
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~